Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced/Metastatic Solid Tumors × trifluridine tipiracil drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 3 Colorectal Cancer Metastatic 3 Advanced Solid Tumors 3 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Gastric and Gastroesophageal Junction Adenocarcinoma 1 ESCC 1 Anal Cancer Metastatic 1 Advanced/Metastatic Solid Tumors 1

Interventions

trifluridine tipiracil drug combination 1 pembrolizumab 1 Trifluridine 1 Standard of Care 1 Injections 1 HMPL-013 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05405595 2026-01-07

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Adagene Inc

Phase 1/2 Recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡